Form 8-K/A

Vivos Therapeutics, Inc., 8-K/A filed 2026-09-08

Published 8 Sep 2026 · retrieved 9 Sep 2026, 02:30 EDT · version 1Official source

The full text was pulled automatically from the official source and is not Threadline News reporting; the annotations alongside it are.

Filing record

1

8-K/A filed with the Securities and Exchange Commission by Vivos Therapeutics, Inc. (CIK 0001716166) on 2026-09-08.

2

Accession number 0001493152-26-041807. EDGAR reports the filing package as 241 KB. The filing index, including every exhibit, is at https://www.sec.gov/Archives/edgar/data/1716166/000149315226041807/0001493152-26-041807-index.htm.

Items reported on the cover

1

Item 1.01: Entry into a Material Definitive Agreement

2

Item 3.02: Unregistered Sales of Equity Securities

3

Item 9.01: Financial Statements and Exhibits